Leukaemia & Lymphoma Research publishes peer reviewed scientific manuscripts on current trends in oncology medicine as well as ground breaking research developments on the diagnosis and treatment of blood cancer and bone marrow defects. The journal adscititiously publishes articles that showcase novel insights into the molecular mechanism of DNA mutations, genetic changes and clonal evolution of tumorigenic haematopoietic cells. Only material that has not been published aforetime (either in print or electronically) and is not under consideration for publication elsewhere, with the exception of an abstract that is less than 400 words in length, will be considered for publication.  Authors who submit aforetime published work to the journal will be vetoed from submitting future manuscripts to the journal, and their funding body and/or institution will be notified. All contributions, including solicited Perspectives on Diabetes, are critically reviewed by the editors and, if felt to be congruous for the journal and potentially competitive, invited referees. Reviewers comments, when available, are provided to authors. The exceptions are commentaries, all of which are by invitation only and reviewed only by the invited editor. The decision of the editors is final. Authors are welcome to suggest the denominations of individuals they consider qualified to accommodate as reviewers. The international journals are among the best open access journals in the world, set out to publish the most comprehensive, pertinent and reliable information predicated on the current research and development on a variety of subjects. This information can be published in our peer reviewed journal with impact factors and are calculated utilizing citations not only from research articles but adscititiously review articles (which incline to receive more citations), editorials, letters, meeting abstracts, short communications, and case reports. The inclusion of these publications provides the opportunity for editors and publishers to manipulate the ratio used to calculate the impact factor and endeavor to increment their number expeditiously. Impact factor plays a major role for the particular journal.